Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transport protein 2A (NaPi-2a) is a membrane transporter primarily localized to the renal proximal tubule brush border membrane, where it facilitates the active reabsorption of phosphate from the filtrate via sodium-coupled cotransport, accounting for approximately 70–80% of phosphate reabsorption in the kidney[3][6][1]. This protein, encoded by the SLC34A1 gene, is regulated by parathyroid hormone and plays a crucial role in maintaining systemic phosphate homeostasis. Mutations in SLC34A1 can lead to disorders such as hypophosphatemia with kidney stones and/or osteoporosis[3][6]. The cotransporter typically operates with a stoichiometry of 3 sodium ions per one divalent phosphate ion, making the process electrogenic[3].
Substrate (transporter for phosphate and sodium ions); Electrogenic sodium-phosphate cotransport
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transport protein 2A (NaPi-2a).